These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 38339026)

  • 1. Can Some Anticancer Drugs Be Repurposed to Treat Amyotrophic Lateral Sclerosis? A Brief Narrative Review.
    Potenza RL; Armida M; Popoli P
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro.
    Duan QQ; Wang H; Su WM; Gu XJ; Shen XF; Jiang Z; Ren YL; Cao B; Li GB; Wang Y; Chen YP
    BMC Med; 2024 Mar; 22(1):96. PubMed ID: 38443977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients.
    Imamura K; Izumi Y; Banno H; Uozumi R; Morita S; Egawa N; Ayaki T; Nagai M; Nishiyama K; Watanabe Y; Hanajima R; Oki R; Fujita K; Takahashi N; Ikeda T; Shimizu A; Morinaga A; Hirohashi T; Fujii Y; Takahashi R; Inoue H
    BMJ Open; 2019 Dec; 9(12):e033131. PubMed ID: 31796494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis.
    Gold ND; Mallard AJ; Hermann JC; Zeifman RJ; Pagni BA; Bogenschutz MP; Ross S
    J Palliat Med; 2023 Oct; 26(10):1408-1418. PubMed ID: 37167080
    [No Abstract]   [Full Text] [Related]  

  • 5. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.
    Conde B; Winck JC; Azevedo LF
    Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signature-Based Computational Drug Repurposing for Amyotrophic Lateral Sclerosis.
    Papikinos T; Krokidis MG; Vrahatis A; Vlamos P; Exarchos TP
    Adv Exp Med Biol; 2023; 1424():201-211. PubMed ID: 37486495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purinergic P2X
    Mckenzie ADJ; Garrett TR; Werry EL; Kassiou M
    ACS Chem Neurosci; 2022 May; 13(10):1479-1490. PubMed ID: 35512313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breaking barriers with tofersen: Enhancing therapeutic opportunities in amyotrophic lateral sclerosis.
    Saini A; Chawla PA
    Eur J Neurol; 2024 Feb; 31(2):e16140. PubMed ID: 37975798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyotrophic lateral sclerosis with upper motor neuron predominance: diagnostic accuracy of qualitative and quantitative susceptibility metrics in the precentral gyrus.
    Lo Russo F; Contarino VE; Conte G; Morelli C; Trogu F; Casale S; Sbaraini S; Caschera L; Genovese V; Liu C; Cinnante CM; Silani V; Triulzi FM
    Eur Radiol; 2023 Nov; 33(11):7677-7685. PubMed ID: 37606662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis.
    Fiscon G; Conte F; Amadio S; Volonté C; Paci P
    Neurotherapeutics; 2021 Jul; 18(3):1678-1691. PubMed ID: 33987813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs in clinical development for the treatment of amyotrophic lateral sclerosis.
    Martinez A; Palomo Ruiz MD; Perez DI; Gil C
    Expert Opin Investig Drugs; 2017 Apr; 26(4):403-414. PubMed ID: 28277881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment for familial amyotrophic lateral sclerosis/motor neuron disease.
    Benatar M; Kurent J; Moore DH
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD006153. PubMed ID: 19160266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases.
    Quinn C; Elman L
    Continuum (Minneap Minn); 2020 Oct; 26(5):1323-1347. PubMed ID: 33003004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyotrophic lateral sclerosis mimics.
    Kwan J; Vullaganti M
    Muscle Nerve; 2022 Sep; 66(3):240-252. PubMed ID: 35607838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapeutic agent 5-fluorouracil increases survival of SOD1 mouse model of ALS.
    Rando A; de la Torre M; Martinez-Muriana A; Zaragoza P; Musaro A; Hernández S; Navarro X; Toivonen JM; Osta R
    PLoS One; 2019; 14(1):e0210752. PubMed ID: 30640943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β2-Adrenoceptor agonists as novel, safe and potentially effective therapies for Amyotrophic lateral sclerosis (ALS).
    Bartus RT; Bétourné A; Basile A; Peterson BL; Glass J; Boulis NM
    Neurobiol Dis; 2016 Jan; 85():11-24. PubMed ID: 26459114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creatine for amyotrophic lateral sclerosis/motor neuron disease.
    Pastula DM; Moore DH; Bedlack RS
    Cochrane Database Syst Rev; 2010 Jun; (6):CD005225. PubMed ID: 20556761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update.
    Mohi-Ud-Din R; Mir RH; Shah AJ; Sabreen S; Wani TU; Masoodi MH; Akkol EK; Bhat ZA; Khan H
    Curr Neuropharmacol; 2022; 20(1):179-193. PubMed ID: 33913406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Scler osis (ALS) as Neurodegenerative Diseases and their Treatments: A Review Study.
    Deeb O; Nabulsi M
    Curr Top Med Chem; 2020; 20(26):2391-2403. PubMed ID: 32972341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.